Loading clinical trials...
Loading clinical trials...
Efficacy of an HSV2 Genital Herpes Suppressive Treatment on HIV and HSV2 Genital Shedding Among Co-Infected Patients Receiving or Not Antiretroviral Drugs
Conditions
Interventions
Valacyclovir
Locations
1
Burkina Faso
Service d'Hygiene du Centre Muraz
Bobo-Dioulasso, Burkina Faso
Start Date
August 1, 2004
Completion Date
July 1, 2005
Last Updated
June 7, 2006
NCT04929028
NCT04142047
NCT06694805
NCT07428330
NCT07225530
NCT06665646
Lead Sponsor
French National Agency for Research on AIDS and Viral Hepatitis
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions